Calibrant Biosystems

Calibrant Biosystems is a biotechnology company dedicated to the discovery and development of protein drug targets and markers for the treatment and diagnosis of diseases. It provides various therapeutic approaches, protein drug targets, disease pathways, and biomarkers from microdissected human tissue specimens. The company offers treatments for a variety of cancer indications, including ovarian cancer and primary brain cancer.